JOINDER AND SECOND LOAN MODIFICATION AGREEMENTJoinder and Second Loan Modification Agreement • October 23rd, 2020 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus
This Joinder and Second Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of October 19, 2020, by and among (a) SILICON VALLEY BANK, a California corporation (“Bank”), (b) (i) INTERPACE BIOSCIENCES, INC., (f/k/a Interpace Diagnostics Group, Inc.) a Delaware corporation (“IDG”), (ii) INTERPACE DIAGNOSTICS CORPORATION, a Delaware corporation (“IDC”), and (iii) INTERPACE DIAGNOSTICS, LLC, a Delaware limited liability company (“IDLLC”) (IDG, IDC and IDLLC are hereinafter jointly and severally, individually and collectively, referred to as “Existing Borrower”), and (c) INTERPACE PHARMA SOLUTIONS, INC., a Delaware corporation (“New Borrower”) (New Borrower and Existing Borrower, are hereinafter jointly, severally, individually and collectively, “Borrower”).
